FLAVOKAVAIN A(P)

CAS No. 37951-13-6

FLAVOKAVAIN A(P)( —— )

Catalog No. M20438 CAS No. 37951-13-6

FLAVOKAVAIN A(P) a novel chalcone from kava extract induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 65 In Stock
25MG 108 In Stock
50MG 159 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FLAVOKAVAIN A(P)
  • Note
    Research use only, not for human use.
  • Brief Description
    FLAVOKAVAIN A(P) a novel chalcone from kava extract induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
  • Description
    FLAVOKAVAIN A(P) a novel chalcone from kava extract induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    37951-13-6
  • Formula Weight
    314.33
  • Molecular Formula
    C18H18O5?
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (79.53 mM)
  • SMILES
    COc1ccc(cc1)\C=C\C(=O)c1c(O)cc(OC)cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Niu L Ding L Lu C et al. Flavokawain A Inhibits Cytochrome P450 in in vitro Metabolic and Inhibitory Investigations[J]. Journal of Ethnopharmacology 2016:S0378874116304007.
molnova catalog
related products
  • DMU2139

    DMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).

  • CYP1B1-IN-5

    CYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.

  • Praeruptorin A (b)

    Praeruptorin A could exhibit its anti-osteoclastogenic activity by inhibiting p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca(2+) oscillation.